Learn about the validation and clinical implemenation of BRCAPlus.
Ambry BRCAplus Validation and Hereditary Multigene Panels publications
Vice President, Research and Development
Dr. Elliott received his undergraduate degree in Biology from Franklin and Marshall College and went on to do his Genetics Ph.D. training at Thomas Jefferson University and Johns Hopkins University School of Medicine. His thesis involved studying the role of CREB-binding protein in germline and stem cell development. Dr. Elliott conducted his postdoctoral training in the cancer stem cell department at the Novartis Institute for Functional Genomics in San Diego, CA., where he studied potential drug targets for chemotherapeutic resistance and identified the first mitochondrial ABC transporter implicated in cancer drug resistance.
Dr. Chao graduated with honors from UCLA with a B.S. in Microbiology and Molecular Genetics and received her M.D. from the University of California, Irvine. She completed her training in Clinical Molecular Genetics at the Children's Hospital of Philadelphia (CHOP) and previously served as Associate Director of the Genetic Diagnostic Lab at the University of Pennsylvania. As a Howard Hughes Scholar at the National Human Genome Research Institute (NHGRI), Dr. Chao specialized in genomic technologies such as the development of array-CGH, and applications to cancer genetics. Currently, Dr. Chao is also on faculty at UC Irvine where her research focuses on novel methods for interpreting DNA variants in genomic data sets.
- Wed, June 11, 2014
- 1:00pm PDT
- Duration: 46 minutes
- C.E.U. --
- P.A.C.E. --